- alias::
  ICD-11_Code::
  tags:: #Disease
- ## Etiology
  background-color:: blue
	- ### Causative Agents
	- ### Risk Factors
- ## Epidemiology
  background-color:: blue
	- ### Incidence
	- ### Prevalence
		- ### Demographics
	- ### Geographic Distribution
- ## Pathophysiology
  background-color:: blue
	- ### Mechanism of Disease
	- ### Affected Systems/Organs
- ## Clinical Features
  background-color:: blue
	- ### Clinical Presentation
		- #### Symptoms #eye-prof-card #card
		  deck:: Eye
		  id:: c3f181b7-5dfb-4fd9-a503-6b6249eca219
			- Pain
			- Photophobia
			- Lacrimation(Watering)
			- Blepharospasm
			- Diminished Vision
		- #### Signs #eye-prof-card #card
		  deck:: Eye
		  id:: f8af9f1a-4fe3-48a6-a259-5fd572502c34
			- Ciliary Congestions (redness around cornea)
			- [[Hypophon]]
	- ### Stages or Classification
	- ### Diagnostic Criteria
- ## Diagnosis
  background-color:: blue
	- ### Clinical Diagnosis
		- #### Classical Presentation
		- #### Probable Diagnosis
	- ### Investigations ‬‭ #eye-prof-card #card
	  deck:: Eye
	  id:: 6747af2c-41e7-4b9a-85c5-2d982358243b
		- Corneal Scraping and the
		  logseq.order-list-type:: number
			- Gram staining
			  logseq.order-list-type:: number
			- Giemsa staining
			  logseq.order-list-type:: number
			- KOH preparation
			  logseq.order-list-type:: number
			- C/S
			  logseq.order-list-type:: number
		- Fluorescein dye test
		  logseq.order-list-type:: number
	- ### Differential Diagnosis
	- ### Confirmation of Diagnosis
- ## Management and Treatment
  background-color:: blue
	- ### Medical Treatment #eye-prof-card #card
	  deck:: Eye
	  id:: 38be0f5c-2a09-4dd4-a846-791180fc9763
		- Board Spectrum Antibiotic (Topical)
		- Systemic Antibiotic
		- [[Atropine 1% Sulphate]]
	- ### Surgical Options
	- ### Lifestyle and Dietary Recommendations
	- ### Follow-up
- ## Prognosis
  background-color:: blue
	- ### Expected Course
		- #### With Treatment
		- #### Without Treatment
			- ##### Possible Complications
			- ##### Long-Term Effects
	- ### Survival Rates
		- #### With Treatment
		- #### Without Treatment
	- ### Quality of Life Considerations
- ## Prevention
  background-color:: blue
	- ### Health Education
	- ### Community Approach
	- ### Screening Programs
	- ### Lifestyle Modifications
- ## Patient Education and Support
  background-color:: blue
	- ### Educational Resources
	- ### Support Groups
	- ### Counseling Options
- ## Recent Research and Developments
  background-color:: blue
	- ### Ongoing Clinical Trials
	- ### Recent Advances
- ## Key Literature
  background-color:: blue
- ## Guidelines and Protocols
  background-color:: blue